<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="363117">
  <stage>Registered</stage>
  <submitdate>6/10/2012</submitdate>
  <approvaldate>19/10/2012</approvaldate>
  <actrnumber>ACTRN12612001117808</actrnumber>
  <trial_identification>
    <studytitle>Remote ischemic preconditioning in obesity and diabetes</studytitle>
    <scientifictitle>The effect of ischemic preconditioning in reducing inflammation and improving glucose homeostasis in obesity.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Obesity</healthcondition>
    <healthcondition>Diabetes</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and nutrition</conditioncode1>
      <conditioncode2>Obesity</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Diabetes</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Ischemic preconditioning will be induced by brief periods of limb ischemia (5mins) due to limb occlusion using a blood pressure cuff inflated to suprasystolic pressure and followed by 5 minutes of reperfusion for 4 cycles. This protocol of 4 cycles of occlusion and resotration of flow will be performed daily for 1 week in this study.</interventions>
    <comparator>Each individual will act as their own control</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Serum levels of IL6 measured in a blood sample</outcome>
      <timepoint>1 week</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Glucose and insulin levels in blood sample.</outcome>
      <timepoint>1 week</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Obesity BMI&gt;30. Patients may not necessarily be diabetic.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Males</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Drug therapy, smokers.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/12/2012</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>36</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Michael Cheung</primarysponsorname>
    <primarysponsoraddress>Dept of Cardiology
Royal Childrens Hospital
Flemington Road
Parkville
Victoria 3052</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Murdoch Childrens Research Institute</fundingname>
      <fundingaddress>Flemington Road 
Parkville
Victoria 3052</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>To determine if preconditioning will have a beneficial effect on the metabolic derangements associated with obesity.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Rosa Masciantonio</name>
      <address>MCRI
Heart Research Group
Flemington Road
Parkville 
Victoria 3052</address>
      <phone>+61-3-93455718</phone>
      <fax />
      <email>rosa.masciantonio@mcri.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Rosa Masciantonio</name>
      <address>MCRI
Heart Research Group
Flemington Road
Parkville 
Victoria 3052</address>
      <phone>+61-3-93455718</phone>
      <fax />
      <email>rosa.masciantonio@mcri.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Rosa Masciantonio</name>
      <address>MCRI
Heart Research Group
Flemington Road
Parkville 
Victoria 3052</address>
      <phone />
      <fax />
      <email>rosa.masciantonio@mcri.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>